One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Catheter-Directed Thrombolysis vs Anticoagulation in Patients With Acute Intermediate-High–risk Pulmonary EmbolismThe CANARY Randomized Clinical Trial
Parham Sadeghipour, MD; Yaser Jenab, MD; Jamal Moosavi, MD; et al.
doi : 10.1001/jamacardio.2022.3591
December 2022, Vol 7, No. 12, Pages 1182-1265
Association of Serial High-Sensitivity Cardiac Troponin T With Subsequent Cardiovascular Events in Patients Stabilized After Acute Coronary SyndromeA Secondary Analysis From IMPROVE-IT
Siddharth M. Patel, MD; Arman Qamar, MD, MPH; Robert P. Giugliano, MD, SM; et al.
Association of Race and Ethnicity With Oral Anticoagulation and Associated Outcomes in Patients With Atrial FibrillationFindings From the Get With The Guidelines–Atrial Fibrillation Registry
Utibe R. Essien, MD, MPH; Karen Chiswell, PhD; Lisa A. Kaltenbach, MS; et al.
Food Insecurity Among Individuals With Cardiovascular Disease and Cardiometabolic Risk Factors Across Race and Ethnicity in 1999-2018
Eric J. Brandt, MD, MHS; Tammy Chang, MD, MPH, MS; Cindy Leung, ScD, MPH; et al.
Effect of Dapagliflozin on Cause-Specific Mortality in Patients With Heart Failure Across the Spectrum of Ejection FractionA Participant-Level Pooled Analysis of DAPA-HF and DELIVER
Akshay S. Desai, MD, MPH; Pardeep S. Jhund, MBCHB, PhD; Brian L. Claggett, PhD; et al.
Concordance Between Patient-Reported Health Data and Electronic Health Data in the ADAPTABLE Trial
Emily C. O’Brien, PhD; Hillary Mulder, MS; W. Schuyler Jones, MD; et al.
Effects of Renal Denervation vs Sham in Resistant Hypertension After Medication EscalationPrespecified Analysis at 6 Months of the RADIANCE-HTN TRIO Randomized Clinical Trial
Michel Azizi, MD, PhD; Felix Mahfoud, MD, MA; Michael A. Weber, MD; et al.
Professional Preferences and Perceptions of Cardiology Among Internal Medicine ResidentsTemporal Trends Over the Past Decade
Meghan York, MD; Pamela S. Douglas, MD; Julie B. Damp, MD; et al.
Time to Clinical Benefit of Dapagliflozin in Patients With Heart Failure With Mildly Reduced or Preserved Ejection FractionA Prespecified Secondary Analysis of the DELIVER Randomized Clinical Trial
Muthiah Vaduganathan, MD, MPH; Brian L. Claggett, PhD; Pardeep Jhund, MD, PhD; et al.
Icosapent Ethyl Supplementation and Cardiovascular Prevention—Implications of Evolving Data
John T. Wilkins, MD, MS; Donald M. Lloyd-Jones, MD, ScM
Catheter-Directed Treatment of Submassive Pulmonary Embolism—A Cautious Step Closer?
Elaine M. Hylek, MD, MPH
A Man in His 20s With Gradually Enlarging Mediastinal Mass and Intermittent Hemoptysis
Ruiyi Yang, MD; Jianqun Yu, MD
Team-Based Digital Gamification to Improve Cardiovascular Health in Women With Hypertensive Disorders of Pregnancy
Zahra Aryan, MD, MPH; Emily A. Gordon, MD; Alfonso H. Waller, MD
Team-Based Digital Gamification to Improve Cardiovascular Health in Women With Hypertensive Disorders of Pregnancy—Reply
Jennifer Lewey, MD, MPH; Mary E. Putt, PhD, ScD; Lisa D. Levine, MD, MSCE
